Cornelia E. Hoesl

Phase I Dose Escalation and Pharmacokinetic Study of BI 2536, a Novel Polo-Like Kinase 1 Inhibitor, in Patients With Advanced Solid Tumors

K. Mross, Annette Frost, Simone Steinbild et al. · Journal of Clinical Oncology · 2008 · 158 citations · Full text

Pharmacy, Oncology, Pharmacology +14

New highly potent GABA uptake inhibitors selective for GAT-1 and GAT-3 derived from (R)- and (S)-proline and homologous pyrrolidine-2-alkanoic acids

Günther Fülep, Cornelia E. Hoesl, Georg Höfner et al. · European Journal of Medicinal Chemistry · 2006 · 51 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Affinity of 1-aryl-1,2,3,4-tetrahydroisoquinoline derivatives to the ion channel binding site of the NMDA receptor complex

Matthias Ludwig, Cornelia E. Hoesl, Georg Höfner et al. · European Journal of Medicinal Chemistry · 2006 · 47 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Parallel Solid-Phase Synthesis of 2-Imino-4-oxo-1,3,5-triazino[1,2-<i>a</i>]benzimidazoles via Tandem Aza-Wittig/Heterocumulene-Mediated Annulation Reaction

Cornelia E. Hoesl, Adel Nefzi, Richard A. Houghten · Journal of Combinatorial Chemistry · 2003 · 37 citations

Pharmacy, Chemistry, Medicinal Chemistry +15

Generation of chiral N-acylpyridinium ions by means of silyl triflates and their diastereoselective trapping reactions: formation of N-acyldihydropyridines and N-acyldihydropyridones

Cornelia E. Hoesl, Markus Maurus, Jörg Pabel et al. · Tetrahedron · 2002 · 32 citations

Natural Sciences, Chemistry, Catalysis +7